Cibus (CBUS) Common Equity (2016 - 2026)
Cibus (CBUS) posted Common Equity of $21.8 million for Q4 2025, down 58.04% sequentially from $52.0 million in Q3 2025, and down 76.31% YoY from $92.2 million in Q4 2024.
Cibus (CBUS) Common Equity (2016 - 2026) Analysis & Trends
Cibus has reported Common Equity for 10 years, with the latest figure at $21.8 million in Q4 2025.
- Quarterly Common Equity fell 76.31% year-over-year to $21.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $21.8 million (down 76.31% YoY) and the FY2025 annual result came in at $21.8 million, down 76.31% from the prior year.
- Common Equity eased to $21.8 million in Q4 2025 per CBUS's latest filing, from $52.0 million in the prior quarter.
- Over five years, Common Equity peaked at $484.3 million in Q2 2023 and troughed at $2.7 million in Q1 2023.
- A 5-year average of $116.9 million and a median of $38.8 million in 2021 frame the typical range for Common Equity.
- The sharpest annual moves came in 2023 and 2024: Common Equity tumbled 82.13% in 2023, then surged 10331.83% in 2024.
- Over 5 years, Common Equity stood at $14.1 million in 2021, then tumbled by 48.82% to $7.2 million in 2022, then jumped by 3957.38% to $293.5 million in 2023, then plunged by 68.6% to $92.2 million in 2024, then plunged by 76.31% to $21.8 million in 2025.
- According to Business Quant data, Common Equity over the past three periods registered $21.8 million, $52.0 million, and $74.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 20.25 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 31.71 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 6.76 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 5.17 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.35 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 757.49 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 9.79 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 22.38 Bn |
| 10 | Cibus | 131.25 Mn | 110.82 Mn | - | 14.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 14.80 Mn |
| Dec 31, 2025 | 21.83 Mn |
| Sep 30, 2025 | 52.03 Mn |
| Jun 30, 2025 | 74.48 Mn |
| Mar 31, 2025 | 73.96 Mn |
| Dec 31, 2024 | 92.16 Mn |
| Sep 30, 2024 | 108.14 Mn |
| Jun 30, 2024 | 270.50 Mn |
| Mar 31, 2024 | 278.22 Mn |
| Dec 31, 2023 | 293.47 Mn |
| Sep 30, 2023 | 463.39 Mn |
| Jun 30, 2023 | 484.31 Mn |
| Mar 31, 2023 | 2.67 Mn |
| Dec 31, 2022 | 7.23 Mn |
| Sep 30, 2022 | 8.84 Mn |
| Jun 30, 2022 | 13.76 Mn |
| Mar 31, 2022 | 14.92 Mn |
| Dec 31, 2021 | 14.13 Mn |
| Sep 30, 2021 | 15.83 Mn |
| Jun 30, 2021 | 21.90 Mn |